News | August 25, 2010

TCT Offers PFO Summit, Nurse, Tech Symposium

August 25, 2010 – There will be special tracks available for nurses and technologists and for the transcatheter treatment of patent foramen ovale (PFO) during the Transcatheter Cardiovascular Therapeutics (TCT) meeting Sept. 21-25, 2010, in Washington, D.C.

TCT for Nurses and Technologists

The 19th Annual Cardiovascular Nurse and Technologist Symposium is being expanded this year to one and a half days. The extended track will better provide a forum for discussion of the latest advances in interventional, pharmacologic, structural heart and endovascular strategies for the management of the cardiovascular patient. Content is presented utilizing didactic lectures, case presentations, panel discussions, hands-on cadaver heart workshops and breakout sessions.

New PFO Summit

Co-organized by the PFO Research Foundation and the Cardiovascular Research Foundation (CFR), this pre-TCT gathering is designed for physicians, industry, research sponsors, regulators and patient advocates. It will allow an exchange of knowledge and develop initiatives in research, education, definition of care standards and patient registries. Experts with diverse perspectives in PFO science will offer a day of presentations, panel discussions, debates and working groups. This is not a passive continuing medical education meeting, but rather a summit for action to advance patient care. The PFO Summit will take place Monday, Sept. 20, from 9 a.m. to 6 p.m. in the Walter E. Washington Convention Center.

For more information: www.tctconference.com

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init